These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20214953)

  • 21. [A new model of multiple sclerosis. Experimental vaccinia infection in the monkey].
    Simon J; Simon O; Hofmann L
    Fortschr Med; 1980 Nov; 98(41):1607-11. PubMed ID: 7009353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reactive changes and the phagocytic activity of the glial cells in pathological processes in the central nervous system].
    Zhabotinskiĭ IuM
    Arkh Patol; 1978; 40(4):70-8. PubMed ID: 678158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical markers of damage of the central nervous system in multiple sclerosis.
    Bartosik-Psujek H; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():389-92. PubMed ID: 11977345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of autoimmunity in multiple sclerosis.
    Whitaker JN; Snyder DS
    CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis - a response-to-damage model.
    't Hart BA; Hintzen RQ; Laman JD
    Trends Mol Med; 2009 Jun; 15(6):235-44. PubMed ID: 19451035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroglial responses to CNS injury: prospects for novel therapeutics.
    Kilpatrick TJ; Butzkueven H; Emery B; Marriott M; Taylor BV; Tubridy N
    Expert Rev Neurother; 2004 Sep; 4(5):869-78. PubMed ID: 15853513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ
    Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis: a battle between destruction and repair.
    McQualter JL; Bernard CC
    J Neurochem; 2007 Jan; 100(2):295-306. PubMed ID: 17101032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A
    Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue.
    Alonso R; Fernández-Fernández AM; Pisa D; Carrasco L
    Neurobiol Dis; 2018 Sep; 117():42-61. PubMed ID: 29859870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rat CNS cell culture. Enhancement of neuronal survival and delay of glial proliferation by serum from patients with multiple sclerosis. A morphological study.
    Savettieri G; Ferraro D; Chiarini A; Cestelli A
    Ital J Neurol Sci; 1984 Sep; 5(3):311-6. PubMed ID: 6209241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Multiple sclerosis: a fever blister on the brain?
    Ellison GW
    Lancet; 1974 Sep; 2(7881):664. PubMed ID: 4137790
    [No Abstract]   [Full Text] [Related]  

  • 36. What if multiple sclerosis isn't an immunological or a viral disease? The case for a circulating toxin.
    Wolfgram F
    Neurochem Res; 1979 Feb; 4(1):1-14. PubMed ID: 377118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection?
    Cosentino M; Zaffaroni M; Giorelli M; Marino F; Ferrari M; Bombelli R; Rasini E; Trojano M; Lecchini S; Livrea P; Comi G; Frigo G
    Trends Pharmacol Sci; 2004 Jul; 25(7):350-1; author reply 351-2. PubMed ID: 15219975
    [No Abstract]   [Full Text] [Related]  

  • 38. Animal toxicity of phytopathogenic fungi.
    Main CE; Hamilton PB
    Appl Microbiol; 1972 Jan; 23(1):193-5. PubMed ID: 5059620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a ciliate protozoan for fungal toxins studies.
    Dive D; Moreau S; Cacan M
    Bull Environ Contam Toxicol; 1978 Apr; 19(4):489-95. PubMed ID: 418834
    [No Abstract]   [Full Text] [Related]  

  • 40. EFFECT OF MONONUCLEAR BLOOD CELLS FROM MULTIPLE SCLEROSIS PATIENTS ON NEUROGLIA IN TISSUE CULTURE.
    BERG O; KAELLEN B
    J Neuropathol Exp Neurol; 1964 Jul; 23():550-9. PubMed ID: 14193257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.